Curaleaf Holdings (CURLF) Total Liabilities (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Total Liabilities of $2.0 billion for Q4 2025, up 2.49% year-on-year from $2.0 billion in Q4 2024, and up 2.49% on a QoQ basis from $2.0 billion in Q4 2024.
Curaleaf Holdings (CURLF) Total Liabilities (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Total Liabilities for 7 consecutive years, with $2.0 billion the latest figure, recorded in Q4 2025.
- Quarterly Total Liabilities rose 2.49% year-over-year to $2.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 billion (up 2.49% YoY) and the FY2025 annual result came in at $2.0 billion, up 2.49% from the prior year.
- Total Liabilities climbed to $2.0 billion in Q4 2025 per CURLF's latest filing, from $2.0 billion in the prior quarter.
- Over the last five years, Total Liabilities for CURLF reached as high as $2.0 billion in Q3 2023 and fell as low as $1.7 million in Q1 2022.
- A 5-year average of $1.6 billion and a median of $1.9 billion in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities jumped 46.23% — and 2022, when it tumbled 99.84%.
- Year by year, Total Liabilities stood at $1.4 billion in 2021, then soared by 39.85% to $2.0 billion in 2022, then declined by 4.39% to $1.9 billion in 2023, then gained by 1.61% to $2.0 billion in 2024, then rose by 2.49% to $2.0 billion in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $2.0 billion, $2.0 billion, and $2.0 billion for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.01 Bn |
| Dec 31, 2024 | 1.96 Bn |
| Sep 30, 2024 | 1.99 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Dec 31, 2023 | 1.93 Bn |
| Sep 30, 2023 | 2.01 Bn |
| Jun 30, 2023 | 2.00 Bn |
| Dec 31, 2022 | 2.01 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.74 Bn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.44 Bn |
| Sep 30, 2021 | 1.41 Bn |
| Jun 30, 2021 | 1.35 Bn |
| Mar 31, 2021 | 1.08 Bn |
| Dec 31, 2020 | 984.72 Mn |
| Sep 30, 2020 | 973.59 Mn |
| Dec 31, 2019 | 333.48 Mn |